Both in Biotechnology
Scilex Holding vs Cel-Sci
Over the past year SCLX returned −83.4% and CVM returned −79.7%; their daily moves had a correlation of 0.02.
SCLX −83.4% CVM −79.7%Growth of $1, one year, split-adjusted
| Metric | SCLX | CVM |
|---|---|---|
| Price | $4.41 | $1.79 |
| Market cap | $31.0M | $31.5M |
| Today | −1.78% | +5.29% |
| 1 month | −18.8% | +14.7% |
| 6 months | −30.3% | −41.7% |
| Year to date | −63.9% | −66.0% |
| 1 year | −84.9% | −80.0% |
| Revenue growth (YoY) | −22.8% | — |
| Gross margin | 51.9% | — |
| Net margin | −1501.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.0× | — |
| Net cash | -$82.5M | $255.6K |
| Dividend yield | — | — |
| Volatility (60d) | 77.3% | 81.5% |
| Short % of float | 2.8% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).